Bone Densitometers Device Market is valued at USD 3.12 Billion in 2020 and expected to reach USD 4.02 Billion by 2027 with the CAGR of 3.70% over the forecast period.
Bone Densitometers Device Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Increasing incidence of disorders like osteoporosis that cause loss of bone density is driving the global bone densitometers device market.
Bone densitometer device is a machine used to detect osteoporosis. It is used to test bone density. This device calculates bone density quickly and accurately. Bone densitometry, also is known as dual energy X-ray absorptiometry, also called DXA or DEXA. It is mainly used to determine osteopenia or osteoporosis, the test uses a very small dose of ionizing radiation to take pictures inside the body, normally the lower spine and hip, to measure bone loss. There are two types of DXA equipment such as a axial device and a peripheral device. Most of the bone densitometer devices used for DXA is axial devices, which are used to measure bone density in the hip and spine. It is usually located in hospitals and medical offices. Additionally, Dual energy X-ray absorptiometry (DXA or DEXA) is the most widely used technique for determining the bone density. DEXA is an improved form of X-ray technology used to measure bone loss. A DEXA device is used for both central and peripheral bone mineral density (BMD) scan. DXA is widely used due to its high precision, easy handling, and safety of usage for both adults and children.
Bone densitometers device market is segmented on the basis of technology, end user and by regional & country level. Based on technology, global bone densitometers device market is classified as axial bone densitometry and peripheral bone densitometry. Based upon axial bone densitometry, global bone densitometers device market is sub-classified as dual energy x-ray absorptiometry (DEXA) and quantitative computed tomography (QCT). Based upon peripheral bone densitometry, global bone densitometers device market is sub-classified as single energy x-ray absorptiometry (SEXA), dual energy x-ray absorptiometry (pDEXA), radiographic absorptiometry (RA), quantitative ultrasound (QUS) and peripheral quantitative computed tomography (pQCT). Based upon end user type, global bone densitometers device market is classified as hospitals, clinics and others.
The regions covered in this bone densitometers device market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of bone densitometers device is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Bone densitometers device market report covers prominent players like Hologic, Inc., Osteometer Meditech Inc., OSTEOSYS Corp., Trivitron Healthcare, BeamMed Ltd., CompuMed, Inc., General Electric Company, DMS Group, Swissray, Medonica Co. LTD, CooperSurgical, Inc., Asclepius Wellness ,Tecnicare Healthcare Company, FURUNO ELECTRIC CO.,LTD, Medilink UK, Demetech AB., KITA, MedWrench, LLC., Dentsply Sirona, Echolight S.p.a., Scanflex Healthcare AB and others.
Trivitron launched Labsystems Diagnostics IVD Factory to house variety of medical devices & equipment under one campus
News: FEB 16, 2016, Trivitron Group launched Labsystems Diagnostics Labsystems Diagnostics IVD Factory to house variety of medical devices & equipment under one campus. This lab was constructed in 25 acres at Trivitron Medical Technology Park in SIPCOT Industrial Estate Chennai to house multiple factories manufacturing variety of medical devices and equipment under one campus.
Increasing incidence of disorders like osteoporosis that cause loss of bone density is driving the global bone densitometers device market. According to International Osteoporosis Foundation, globally, incidence of hip fracture is approximately 1.7 million per year. Moreover, growing geriatric population that possesses high liability toward developing osteoporosis is expected to impel the overall demand for bone densitometers device in forecast period. According to International Osteoporosis Foundation, incidence of hip fracture in men is projected to increase by 240% in women and 310% in men globally by 2050. Also As per IOF, globally, osteoporosis causes more than 8.9 million fractures per year, resulting in an osteoporotic fracture every 3 seconds. Moreover, high cost of bone densitometers and requires huge resources in terms of software and hardware are the major restrains of the global bone densitometers device market. However, technological advancements and government health initiatives to promote awareness about osteoporosis may generate new opportunities for bone densitometers device market in forecast period.
By End User:
|2015 - 2020
|2021 - 2027
|Market Size in 2020:
|USD 3.12 Billion
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2027:
|USD 4.02 Billion
|Tables, Charts & Figures:
|Hologic, Inc., Osteometer Meditech Inc., OSTEOSYS Corp., Trivitron Healthcare, BeamMed Ltd., CompuMed, Inc., General Electric Company, DMS Group, Swissray, Medonica Co. LTD, CooperSurgical, Inc., Asclepius Wellness ,Tecnicare Healthcare Company, FURUNO ELECTRIC CO.,LTD, Medilink UK, Demetech AB., KITA, MedWrench, LLC., Dentsply Sirona, Echolight S.p.a., Scanflex Healthcare AB and others
|By Technology, By End User
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
North America is expected to dominate with largest share of the bone densitometers device market due to technological expansions, presence of prominent companies in this region to improve their R&D capabilities and maintain high medical standards are expected to propel the demand across this region. Moreover, growing geriatric population lifestyle-associated habits that include sedentary lifestyle, alcohol use and smoking are major causes that promote this condition in the male population. These activities are expected to boost the global bone densitometers device market in forecast period. According to International Osteoporosis Foundation, The 44 million people with either osteoporosis or low bone mass represent 55 % of the people aged 50 and older in the United States and Osteoporosis affects approximately 1.4 million Canadians, mainly postmenopausal women and the elderly in Canada.
Europe is second largest market for bone densitometers device and is growing due to rising bone diseases like osteoporosis, presence of key players in bone densitometers device manufacturing and increased growth in research and development. According to International Osteoporosis Foundation, incidence of distal forearm fractures in male and female were estimated 1.7 and 7.3 per 1000 person-years, respectively in Europe. Also, Osteoporosis affects an estimated 75 million people in Europe, USA and Japan.
Asia Pacific is expected to showcase high growth potential due to the growing geriatric population in emerging economies such as China and India. Also, taking government initiatives to control the worse environmental conditions and enhancing healthcare infrastructure in Japan and Australia are also expected to propel the regional growth. According to Organisation for Economic Co-operation and Development(OECD), In high income Asia-Pacific countries, the share of population aged over 65 years is expected to double to reach and on average 27.6% in 2050, whereas the share of population aged over 80 years is expected to triple between 2015-2050 to reach 10.2%. Additionally, high demand to control the increasing prevalence of bone disorders, increasing disposable income, and infrastructural improvements in healthcare facilities. Growing awareness relating to osteoporosis care in the emerging economies, such as India and China, is also going to present the bone densitometers industry with potential growth opportunities in future. According to International Osteoporosis Foundation, projected that more than about 50% of all osteoporotic hip fractures will occur in Asia by 2050.
Frequently Asked Questions (FAQ) :
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®